Levine P, Burnham L, Katzin WM, Vogel P. The role of isoimmunization in the pathogenesis of erythroblastosis fetalis. Am J Obstet Gynecol 1941;42: 925–37.10.1016/S0002-9378(41)90260-0
Freda VJ, Gorman JG, Pollack W. Rh factor: prevention of isoimmunization and clinical trial on mothers. Science 1966;151:828–30.10.1126/science.151.3712.82817746731
Mollison PL, Hughes-Jones NC, Lindsay M, Wessely J. Suppression of primary RH immunization by passively-administered antibody. Experiments in volunteers. Vox Sang 1969;16:421–39.10.1111/j.1423-0410.1969.tb04769.x
Le van Kim C, Mouro I, Chérif-Zahar B, et al. Molecular cloning and primary structure of the human blood group RhD polypeptide. Proc Natl Acad Sci U S A 1992;89:10925–9.10.1073/pnas.89.22.10925504551438298
Chérif-Zahar B, Bloy C, Le Van Kim C, et al. Molecular cloning and protein structure of a human blood group Rh polypeptide. Proc Natl Acad Sci U S A 1990;87:6243–7.10.1073/pnas.87.16.6243545091696722
Simsek S, de Jong CA, Cuijpers HT, et al. Sequence analysis of cDNA derived from reticulocyte mRNAs coding for Rh polypeptides and demonstration of E/e and C/c polymorphisms. Vox Sang 1994;67:203–9.10.1111/j.1423-0410.1994.tb01661.x7801613
Blumenfeld OO, Patnaik SK. Allelic genes of blood group antigens: a source of human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation Database. Hum Mutat 2004;23:8–16.10.1002/humu.1029614695527
Landsteiner K, Wiener AS. An agglutinable factor in human blood recognized by immune sera for rhesus blood. Proc Soc Exp Biol Med 1940;43:223–4.10.3181/00379727-43-11151
Daniels G, Castilho L, Flegel WA, et al. International Society of Blood Transfusion Committee on terminology for red blood cell surface antigens: Macao report. Vox Sang 2009;96:153–6.10.1111/j.1423-0410.2008.01133.x19152607
Colin Y, Chérif-Zahar B, Le Van Kim C, Raynal V, Van Huffel V, Cartron JP. Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood 1991;78: 2747–52.10.1182/blood.V78.10.2747.2747
Singleton BK, Green CA, Avent ND, et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000;95:12–18.10.1182/blood.V95.1.12
Shao CP, Maas JH, Su YQ, Köhler M, Legler TJ. Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang 2002;83:156–61.10.1046/j.1423-0410.2002.00192.x12201845
Sun CF, Chou CS, Lai NC, Wang WT. RHD gene polymorphisms among RhD-negative Chinese in Taiwan. Vox Sang 1998;75:52–7.10.1046/j.1423-0410.1998.7510052.x
Westhoff CM, Vege S, Nickle P, Hue-Roye K, Reid ME. A single nucleotide deletion in RHCE*cE responsible for the D- - haplotype in the Hispanic population. Vox Sang 2010:99 (Suppl):376.
Beckers EA, Porcelijn L, Ligthart P, et al. The RoHar antigenic complex is associated with a limited number of D epitopes and alloanti-D production: a study of three unrelated persons and their families. Transfusion 1996;36:104–8.10.1046/j.1537-2995.1996.36296181919.x8614957
Chen Q, Hustinx H, Flegel WA. The RHCE allele ceSL: the second example for D antigen expression without D-specific amino acids. Transfusion 2006;46:766–72.10.1111/j.1537-2995.2006.00795.x16686844
Westhoff CM. Review: the Rh blood group D antigen... dominant, diverse, and difficult. Immunohematology 2005;21:155–63.10.21307/immunohematology-2019-412
Daniels GL, Faas BH, Green CA, et al. The VS and V blood group polymorphisms in Africans: a serologic and molecular analysis. Transfusion 1998;38:951–8.10.1046/j.1537-2995.1998.381098440860.x9767746
Brumit MC, Carnahan GE, Stubbs JR, Storry JR, Reid ME. Moderate hemolytic disease of the newborn (HDN) due to anti-Rh17 produced by a black female with an e variant phenotype. Immunohematology 2002;18:40–2.10.21307/immunohematology-2019-507
Noizat-Pirenne F, Lee K, Pennec PY, et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood 2002;100:4223–31.10.1182/blood-2002-01-022912393640
Vege S, Westhoff CM. Molecular characterization of GYPB and RH in donors in the American Rare Donor Program. Immunohematology 2006;22:143–7.10.21307/immunohematology-2019-372
Afenyi-Annan A, Bandarenko N. Transfusion practices for patients with sickle cell disease at a major academic medical center. Immunohematology 2006;22:103–7.10.21307/immunohematology-2019-364
Sesok-Pizzini DA, Friedman DF, Smith-Whitley K, Nance SJ. Transfusion support of patients with sickle cell disease at the Children’s Hospital of Philadelphia. Immunohematology 2006;22:121–5.10.21307/immunohematology-2019-368
Yasuda H, Ohto H, Sakuma S, Ishikawa Y. Secondary anti-D immunization by Del red blood cells. Transfusion 2005;45:1581–4.10.1111/j.1537-2995.2005.00579.x16181208
Mota M, Fonseca NL, Rodrigues A, Kutner JM, Castilho L. Anti-D alloimmunization by weak D type 1 red blood cells with a very low antigen density. Vox Sang 2005;88:130–5.10.1111/j.1423-0410.2005.00604.x15720611
Lacey PA, Caskey CR, Werner DJ, Moulds JJ. Fatal hemolytic disease of a newborn due to anti-D in an Rh-positive Du variant mother. Transfusion 1983;23: 91–4.10.1046/j.1537-2995.1983.23283172867.x6404025
Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086–92.10.1046/j.1537-2995.2001.41091086.x11552063
Ambruso DR, Githens JH, Alcorn R, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion 1987;27: 94–8.10.1046/j.1537-2995.1987.27187121485.x3810834
Hashmi G, Shariff T, Zhang Y, et al. Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high-throughput DNA analysis. Transfusion 2007;47:736–47.10.1111/j.1537-2995.2007.01178.x17381634
Hillyer CD, Shaz BH, Winkler AM, Reid M. Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services. Transfus Med Rev 2008;22: 117–32.10.1016/j.tmrv.2007.12.00218353252
Lo YM, Hjelm NM, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734–8.10.1056/NEJM1998121033924029845707
Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008;336:816–18.10.1136/bmj.39518.463206.25229233418390496
Matassi G, Chérif-Zahar B, Raynal V, Rouger P, Cartron JP. Organization of the human RH50A gene (RHAG) and evolution of base composition of the RH gene family. Genomics 1998;47:286–93.10.1006/geno.1997.51129479501
Tilley L, Green C, Poole J, et al. A new blood group system, RHAG: three antigens resulting from amino acid substitutions in the Rh-associated glycoprotein. Vox Sang 2010;98:151–9.10.1111/j.1423-0410.2009.01243.x19744193
Gruswitz F, Chaudhary S, Ho JD, et al. Function of human Rh based on structure of RhCG at 2.1 A. Proc Natl Acad Sci U S A 2010;107:9638–43.10.1073/pnas.1003587107290688720457942
International Society of Blood Transfusion (ISBT) Working Party on Red Cell Immunogenetics and Blood Group Terminology. http://ibgrl.blood.co.uk/ISBTPages/ISBTHome.htm. Accessed 1/4/2011.